Cargando…
A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation
BACKGROUND: No validated disease-specific measures are available to assess health-related quality of life (HRQoL) in adult subjects with immune thrombocytopenic purpura (ITP). Therefore, we sought to develop and validate the ITP-Patient Assessment Questionnaire (ITP-PAQ) for adult subjects with ITP....
Autores principales: | Mathias, Susan D, Bussel, James B, George, James N, McMillan, Robert, Okano, Gary J, Nichol, Janet L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808052/ https://www.ncbi.nlm.nih.gov/pubmed/17316442 http://dx.doi.org/10.1186/1477-7525-5-11 |
Ejemplares similares
-
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective
por: Mathias, Susan D, et al.
Publicado: (2008) -
Update on chronic immune thrombocytopenic purpura (ITP)
por: McMillan, Robert
Publicado: (2009) -
Hereditary Thrombotic Thrombocytopenic Purpura
por: Nusrat, Sanober, et al.
Publicado: (2023) -
Immune thrombocytopenic purpura
por: Zainal, Abir, et al.
Publicado: (2019) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)